| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma. | Clin Cancer Res | 2010 | 1.54 |
| 2 | Biomarkers on melanoma patient T cells associated with ipilimumab treatment. | J Transl Med | 2012 | 1.04 |